The agreement will enable the companies to advance the development of proton therapy treatments.
Based in Sweden, Elekta provides clinical solutions for the treatment of cancer and brain disorders.
US-based company Pulse Biosciences Inc plans to raise $30.04m through the private placement of two million shares of its common stock priced at $15.02 each.
The company plans to use the funds towards working capital and general corporate purposes.
The US-based surgical analytics and integration services company plans to use the funds towards product development and to open a new headquarters in Boston.
Chinese medical devices developer Lepu Medical Technology (Beijing) Co Ltd plans to raise CNY3bn ($454.68m) by issuing exchangeable bonds in a private placement.
The US-based regenerative medicine company plans to use the funds for the development of its Injectable Discosphere Cell Therapy (IDCT) product in the US and Japan.